PPARA and persistent truncus arteriosus: Activation of PPARα either by cardiac-specific overexpression of PPARα gene or by treating mice with the specific PPARα agonist, WY-1463 improved cardiac function, attenuated cardiac fibrosis, and preserved FAO and high-energy phosphates in a mouse model of HF induced by TAC [34].